Advisors Asset Management Inc. Buys 282 Shares of Cigna Group $CI

Advisors Asset Management Inc. raised its position in Cigna Group (NYSE:CI) by 4.6% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 6,419 shares of the health services provider’s stock after buying an additional 282 shares during the quarter. Advisors Asset Management Inc.’s holdings in Cigna Group were worth $2,122,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in CI. Valeo Financial Advisors LLC boosted its holdings in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Nuveen LLC bought a new position in shares of Cigna Group in the first quarter worth about $727,905,000. Price T Rowe Associates Inc. MD lifted its holdings in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. GQG Partners LLC boosted its stake in shares of Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Cigna Group by 38.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after purchasing an additional 457,052 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on CI shares. Morgan Stanley reissued an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a report on Friday, October 31st. Sanford C. Bernstein dropped their target price on Cigna Group from $346.00 to $294.00 and set a “market perform” rating for the company in a research report on Wednesday, November 12th. Jefferies Financial Group restated a “buy” rating and set a $310.00 price target on shares of Cigna Group in a report on Monday, November 3rd. Truist Financial cut their target price on shares of Cigna Group from $375.00 to $310.00 in a research report on Friday, October 31st. Finally, Wolfe Research decreased their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $334.05.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $277.28 on Friday. The stock’s 50 day moving average price is $284.99 and its 200-day moving average price is $297.30. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company has a market capitalization of $74.07 billion, a PE ratio of 15.14, a PEG ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same quarter in the prior year, the company earned $7.51 EPS. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is presently 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.